Sidley Austin has advised Werewolf Therapeutics. Cooley has advised Ambros Therapeutics. Latham & Watkins has advised the placement agents. Werewolf Therapeutics, Inc. (NASDAQ: HOWL) and Ambros...
Werewolf and Ambros Therapeutics Announce All-Stock Merger and $150 Million Private Placement
Obsidian Therapeutics and Galera Therapeutics Announce $350 Million Merger and Private Placement
Goodwin Procter LLP has advised Obsidian Therapeutics. Sidley Austin LLP has advised Galera Therapeutics. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised the placement...
Sensei Biotherapeutics Acquires Faeth Therapeutics
Sidley has advised Sensei Biotherapeutic on the transaction. Cooley has advised Faeth Therapeutics. Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a Nasdaq-listed clinical-stage biotechnology company, has acquired Faeth...
BioCryst Pharmaceuticals to Acquire Astria Therapeutics for $920 Million
Covington & Burling LLP has advised BioCryst Pharmaceuticals, Inc., and Sidley Austin LLP has advised Astria Therapeutics, Inc. BioCryst Pharmaceuticals, Inc. has entered into a definitive...
Roche to Acquire 89bio in $3.5 Billion Merger Agreement
Sidley Austin has advised Roche, and Gibson, Dunn & Crutcher LLP has advised 89bio, Inc. Roche has entered into a definitive merger agreement to acquire 89bio,...
Soho House to Be Taken Private in $2.7 Billion Deal
Sidley has advised Soho House & Co Inc.; Fried Frank has advised the Special Committee of Soho House & Co Inc.; Herbert Smith Freehills Kramer has...
Roche’s $1.5 Billion Acquisition of Poseida Therapeutics
Sidley Austin represented Roche in the transaction, and Cooley represented Poseida Therapeutics. Roche, one of the world’s largest biotechnology companies and the global leader in in-vitro...
GlycoMimetics’ Acquisition of Crescent Biopharma
Sidley Austin is advising GlycoMimetics, Inc. on the transaction, and Gibson, Dunn & Crutcher is advising Crescent Biopharma, Inc. GlycoMimetics, Inc. (NASDAQ: GLYC) announced it has...
Ocuphire Pharma’s Acquisition of Opus Genetics
Sidley Austin represented Ocuphire Pharma, Inc. in the transaction, and Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan represented Opus Genetics Inc. Wilson Sonsini Goodrich & Rosati...
Metropolis $1.8 Billion Financing and Take-Private of SP
Sidley Austin LLP served as legal advisor to Eldridge in the transaction, while Willkie Farr & Gallagher LLP, Fenwick & West LLP and Latham & Watkins...
Anthelion Capital’s Acquisition of Energy Business from Proterra
Sidley Austin represented Anthelion Capital Holdings (formerly known as Cowen Sustainable Investments) in the transaction. Anthelion Capital Holdings (formerly known as Cowen Sustainable Investments), announced the acquisition...
Pyxis Oncology’s Acquisition of Apexigen
Sidley Austin LLP advised Pyxis Oncology, Inc. on the transaction, while Wilson Sonsini advised Apexigen on the transaction. Pyxis Oncology, Inc., a clinical-stage company, and Apexigen,...